Clinical Trial Update: Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer [Phase 2]

View source ↗

Summary

Phase 2 study assessing nivolumab and ipilimumab as maintenance therapy in unresectable locally advanced or metastatic urothelial cancer has completed. The upda…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Cancer

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Spanish Oncology Genito-Urinary Group | Conditions: Urothelial Cancer | Phase 2 | Status: COMPLETED